Potential for Novel Biomarkers in Diabetes-Associated Chronic Kidney Disease: Epigenome, Metabolome, and Gut Microbiome.

Lecamwasam, Ashani; Ekinci, Elif I; Saffery, Richard; Dwyer, Karen M

Lecamwasam, Ashani; Ekinci, Elif I; Saffery, Richard; Dwyer, Karen M.

Afiliação

Lecamwasam A; Epigenetics Group, Murdoch Children's Research Institute, Parkville, VIC 3052, Australia.
Ekinci EI; Department of Endocrinology, Austin Health, Ivanhoe, VIC 3079, Australia.
Saffery R; School of Medicine, Faculty of Health, Deakin University, Geelong Waurn Ponds, VIC 3220, Australia.
Dwyer KM; Department of Endocrinology, Austin Health, Ivanhoe, VIC 3079, Australia.

Biomedicines ; 8(9)2020 Sep 10.

Article em En | MEDLINE | ID: mdl-32927866

Palavras-chave

biomarker; chronic kidney disease; diabetes; epigenetics; gut microbiome; metabolomics

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Risk_factors_studies Idioma: En Revista: Biomedicines Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Austrália

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google